Following the sale, Biocon’s shareholding in Syngene has come down to 52.46%. Shares of Biocon Ltd ended at ₹368.25, down by ₹1.15, or 0.31%, on the BSE.
Following the sale, Biocon’s shareholding in Syngene has come down to 52.46%. Shares of Biocon Ltd ended at ₹368.25, down by ₹1.15, or 0.31%, on the BSE.